BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
FACILITIES: European headquarters in Leiden
R&D Facilities in Palo Alto, Calif.; Leiden; Netherlands
Manufacturing facilities in Rochester, N.Y.; Wuxi, China; Arroyito, Argentina;
Hanko and Jamsankoski, Finland; Bruges, Belgium; and Beloit, Wis.
STOCK-FINANCIAL HISTORY: Privately held by parent
Formerly listed on NASDAQ--GCOR:
Revenue $410.417M (YE 04) compared to $383.162M (YE 03)
Net income $26.178M (YE 04) compared to $22.808M (YE 03)
Earnings per share $0.32/share (YE 04) compared to $0.26/share (YE 03)
Average shares outstanding 59.434M (YE 04) compared to 58.767M (YE
03)
Total assets $752.113M (YE 04) compared to $712.422M (YE 03)
SUBSIDIARY OF: Danisco A/S
BUSINESS STRATEGY: Develop, manufacture and market products for healthcare, agriculture,
industrial, and consumer markets using molecular biology and protein
chemistry
AGREEMENTS: Name Products Content of Agreement Date
Ablynx Ablynx's Nanobody drug discovery 9/04
platform against tumor
targets specified by
Genencor
collaboration
BioMarin
Genencor to perform contract research 4/06
Pharmaceutical research services for agreement
Inc.
BioMarin
CAMR sterilization process for
medical instruments,
rendered animal
material and human
blood supply
R&D agreement 8/01
Cargill biocatalysts for wet corn exclusive supply 1/01
milling facilities
agreement
Gyros microfluidics technology
collaboration
5/01
Integrated
Genomics
microbial genome
sequencing
technologies
Mayo Clinic transgenic mouse for
celiac disease
Protein Polymer Genencor biomaterials
Technologies and technology and
personal care product
applications
licensing
agreement
cooperative R&D
agreement
licensing and
development
agreement,
expanded 3/05
RESEARCH & DEVELOPMENT: Industrial enzymes for use in cleaning, textile, starch, animal feed, food and
biochemical industries
Protein chemistry and genetic engineering
High-expression fungal and bacterial technology
Fine and specialty chemicals based on novel biocatalysts and diols
technology
Biosynthetic peptides
Human Immunology platform
Conversion of biomass to ethanol to reduce the USA's dependence on
foreign oil
PRODUCTS ON MARKET: Through utilization of our i-biotech solution, more than 250 biotechnology
products, including:
IndiAge® and Primafast® (textile processing)
Laminex® (brewing enzymes)
Spezyme® (grain processing enzymes)
Multifect® (food enzymes)
Euro® (textile cellulases)
Copyright ©2006 AHC Media ® 168
9/01
1/01
12/00